In this regard, it may be suggested that increased MRP1 expression in high grade gliomas, such as glioblastoma multiforme, contribute to chemoresistance through increased drug efflux and reduced bioavailability of the administered chemotherapeutic within the cancerous cell. This evidence concerns the gene ABCC1 and glioblastoma.